Key result
FFRCT outperforms CTA, SPECT, and PET for detecting ischemia-causing lesions with an AUC of 0.94.
Why the study?
FFRCT has emerged as a promising noninvasive test to assess hemodynamic severity of CAD but has not yet been compared with traditional functional imaging for ischemia diagnosis.
Does FFRCT improve diagnostic accuracy for ischemia-causing lesions compared to coronary CTA, SPECT, and PET in patients with suspected stable CAD?
Population
208 patients with suspected stable CAD
Comparison
FFRCT vs coronary CTA, SPECT, and PET
Design
Prospective subanalysis with core laboratory image interpretation
Authors
Loading...
FFRCT demonstrates superior diagnostic performance for vessel-specific ischemia compared to standard coronary CTA, SPECT, and PET, provided the CTA images are evaluable.
Observational (n=208)
Does FFRCT improve diagnostic accuracy for ischemia-causing lesions compared to coronary CTA, SPECT, and PET in patients with suspected stable CAD?
p-value: p=< 0.01
FFRCT demonstrates superior diagnostic performance for vessel-specific ischemia compared to standard coronary CTA, SPECT, and PET, provided the CTA images are evaluable.
Driessen et al. (2019) conducted an observational in suspected stable CAD (n=208). Fractional flow reserve from coronary CTA (FFRCT) vs. Coronary CTA, SPECT, and PET was evaluated on Identification of ischemia-causing lesions (per-vessel AUC) (p=< 0.01). FFRCT yielded a significantly greater per-vessel AUC for identifying ischemia-causing lesions (0.94) compared to coronary CTA (0.83), SPECT (0.70), and PET (0.87) (p<0.01 for all).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: